Navigation Links
Chinese Imitations vs Medtronic and DePuy Synthes: Rapid Growth Expected in the Chinese Spinal Implant Market

Vancouver, BC (PRWEB) August 07, 2014

August 7, 2014 – Vancouver, BC – According to spinal implant market data released by iData Research (, the open surgery spinal implant market in China is projected to be worth over $1 billion by 2019. While DePuy Synthes and Medtronic compete for this market’s top position, domestic competitors collectively threaten both companies by driving down selling prices. Local Chinese medical device providers do not face the same production and distribution costs that international superpowers like DePuy Synthes and Medtronic have to handle.

“Not all, but many local Chinese competitors in this market imitate imported device designs, despite patent laws,” explains Dr. Kamran Zamanian, CEO of iData. “These sell for a fraction of the cost of their imported equivalents and ultimately hold back the overall market value.” For more complex and dangerous spinal implant surgeries, Chinese surgeons tend to favor official DePuy Synthes and Medtronic products.
Other key findings from the iData Research report entitled Chinese and Taiwanese Markets for Spinal Implants:

Domestic Preferences for Degenerative Disease Treatment: Out of the total number of thoracolumbar spinal implant procedures performed in China, 75% were for the treatment of degenerative diseases. Domestically manufactured products are chosen frequently for the treatment of this type of indication, as it tends to involve a less complicated procedure.

Better Health Insurance Coverage: Not only are more Chinese citizens being covered by health insurance, but also more of them are expecting proper medical treatment. This cultural shift, combined with economic development, is one of the main drivers of the Chinese spinal implant market.

  •     Potential Loss in Consumer Confidence: Domestically produced spinal implants that imitate the designs of global market leaders may not be held to as high production standards. If an increased rate of surgical complication becomes apparent, especially in the delicate spinal region, consumers may lose confidence in all corrective spinal surgery products.

As a counter-measure, companies like Medtronic are starting to change their market strategy. The largest local competitor in China is Wei Gao; in 2007, Medtronic purchased 15% equity in this company. Then, in 2012, Medtronic acquired KangHui Holdings, a Chinese orthopedics company, for $816 million. The acquisition of KangHui specifically allows Medtronic to produce and sell lower-end products, which are in high demand in China. Other competitors in the Chinese spinal implant market include Stryker, Zimmer, B. Braun Aesculap, LDR, Paradigm Spine and Alphatec Spine.
For more information
The 2014 Asia-Pacific Spinal Implant and Vertebral Compression Fracture market report includes Spinal Fusion, Thoracolumbar Fixation, Cervical Artificial Disc, Interbody Fusion, Artificial Disc, Dynamic Stabilization and Vertebral Compression Fracture.

About iData Research
iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Diagnostic Medical Imaging Equipment Industry Global and Chinese Analysis for 2009-2019 in New Research Report at
2. Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at
3. Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at
4. Global and Chinese beta-Carotene Industry (CAS 7235-40-7) 2009-2019 Market Research Report Now Available at
5. Global and Chinese Sildenafil Citrate Industry (CAS 171599-83-0) 2019 Forecasts in New Research Report at
6. Chinese researchers describe impaired self-face recognition in those with major depressive disorder
7. Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at
8. UCLA addresses lost in translation issues in Chinese medicine
9. A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L
10. Ancient Chinese medicine put through its paces for pancreatic cancer
11. Sacramento Acupuncture and Traditional Chinese Medicine Specialists Tian Chao Herbs & Acupuncture Now Offering Massage Therapy
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve ... engagement.” The patient is doing more than filling out a survey; in many cases ... an increasing emphasis in health care and research on the importance of active engagement ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: